MACROGENICS INC - COM (MGNX)

Historical Holders from Q1 2014 to Q3 2025

Symbol
MGNX on Nasdaq
CUSIP
556099109
Type / Class
Equity / COM
Shares outstanding
62.9M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
46M
Holdings value
$77.3M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
101
Number of buys
45
Number of sells
-51
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of MACROGENICS INC - COM (MGNX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Bellevue Group AG 15.7% $17.7M 9.93M Bellevue Group AG Jun 1, 2025
ARMISTICE CAPITAL, LLC 9.98% -0.1% $11.3M $35.8K 6.3M +0.32% Armistice Capital, LLC Mar 31, 2025
WASATCH ADVISORS LP 3.1% -41.7% $3.28M -$2.58M 1.95M -44.1% Wasatch Advisors LP Sep 30, 2025
BlackRock, Inc. 2.9% $2.19M 1.81M BlackRock, Inc. Jun 30, 2025
MILLENNIUM MANAGEMENT LLC 2.7% $3.09M 1.72M Millennium Management LLC Mar 31, 2025
Frazier Life Sciences Public Fund, L.P. 2.5% $2.49M 1.55M Frazier Life Sciences Public Fund, L.P. Jun 30, 2025

Institutional Holders of MACROGENICS INC - COM (MGNX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 46M $77.3M -$2.55M $1.68 101
2025 Q2 48.3M $58.4M -$6.82M $1.21 109
2025 Q1 53.8M $68.3M -$6.56M $1.27 124
2024 Q4 56.1M $182M +$1.57M $3.25 125
2024 Q3 54.9M $181M -$21.6M $3.29 121
2024 Q2 60.8M $258M -$143M $4.25 141
2024 Q1 64.8M $953M +$47.9M $14.72 160
2023 Q4 61.8M $595M +$41.9M $9.62 134
2023 Q3 58M $270M -$10.6M $4.66 125
2023 Q2 60M $321M +$4.9M $5.35 128
2023 Q1 58.4M $419M +$13.1M $7.17 134
2022 Q4 56.7M $380M +$1.1M $6.71 131
2022 Q3 57.5M $199M -$24.3M $3.46 124
2022 Q2 62.6M $185M -$36.7M $2.95 122
2022 Q1 60.3M $531M +$3.19M $8.81 137
2021 Q4 57.2M $918M -$24.9M $16.05 149
2021 Q3 57.9M $1.21B -$1.58M $20.94 147
2021 Q2 57.2M $1.54B +$8.98M $26.86 145
2021 Q1 56M $1.78B +$84.4M $31.85 173
2020 Q4 53.8M $1.23B -$5.37M $22.86 141
2020 Q3 53.1M $1.34B +$57.7M $25.19 136
2020 Q2 50.7M $1.41B +$299M $27.92 132
2020 Q1 44.1M $256M -$13.9M $5.82 115
2019 Q4 45.5M $495M -$13.4M $10.88 122
2019 Q3 46.5M $593M -$12.4M $12.76 120
2019 Q2 46.9M $796M +$190M $16.97 129
2019 Q1 44M $791M +$151M $17.98 153
2018 Q4 36.8M $467M -$29.7M $12.70 125
2018 Q3 36.8M $789M -$34M $21.44 127
2018 Q2 38.4M $794M +$10.3M $20.65 126
2018 Q1 37.7M $949M +$115M $25.16 131
2017 Q4 33.6M $638M +$15.1M $19.00 115
2017 Q3 31.6M $583M +$5.3M $18.48 112
2017 Q2 31.3M $549M +$40.9M $17.51 112
2017 Q1 28.9M $537M +$37.8M $18.60 111
2016 Q4 29.1M $594M -$14.3M $20.44 127
2016 Q3 28.2M $844M +$4.37M $29.91 128
2016 Q2 28.1M $759M +$13.8M $26.99 120
2016 Q1 27.9M $523M +$2.53M $18.75 123
2015 Q4 27.6M $856M +$11.4M $30.97 128
2015 Q3 27.2M $582M +$103M $21.42 120
2015 Q2 21.9M $831M +$77.8M $37.97 128
2015 Q1 19.8M $620M +$92.8M $31.37 109
2014 Q4 16.8M $590M +$46.6M $35.07 107
2014 Q3 15.4M $322M +$1.94M $20.90 84
2014 Q2 15.3M $332M -$45.8M $21.73 89
2014 Q1 14.3M $398M +$112M $27.83 75